DianeMDoneganMD

PubMed

• Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
  Alice Y Chang, Sasan Mirfakhraee, Elizabeth E. King, Jennifer U. Mercado, Diane Donegan, Kevin C. J. Yuen> ;Clinical medicine insights. Endocrinology and diabetes. 2021 Jan 1
• Clinical, biological, radiological, and pathological comparison of sparsely and densely granulated somatotroph adenomas: a single center experience from a cohort of 13...
  Amy A. Swanson, Dana Erickson, Diane Donegan, Sarah M. Jenkins, Jamie J. Van Gompel, John L. D. Atkinson, Bradley J. Erickson, Caterina Giannini> ;Pituitary. 2020 Oct 19
• CLINICAL PRESENTATION AND OUTCOMES OF OPIOID INDUCED ADRENAL INSUFFICIENCY.
  Taoran Li, Diane Donegan, W. Michael Hooten, Irina Bancos> ;Endocrine Practice. 2020 Jun 23
• 4 citations
  Assessment of The Bethesda System for Reporting Thyroid Cytopathology.
  Jennifer Sauter, Heidi D. Lehrke, Xiaotun Zhang, Osamah T Al Badri, Rene Rodriguez-Gutierrez, Danae A. Delivanis, Naykky Singh Ospina, Diane Donegan, Oksana Hamidi, Ni...> ;American Journal of Clinical Pathology. 2019 Sep 9
• 11 citations
  The Impact of Insulin-Like Growth Factor Index and Biologically Effective Dose on Outcomes After Stereotactic Radiosurgery for Acromegaly: Cohort Study.
  Christopher S. Graffeo, Diane Donegan, Dana Erickson, Paul D. Brown, Avital Perry, Michael J. Link, William F. Young, Bruce E. Pollock> ;Neurosurgery. 2019 Sep 1
• Not a Grave Finding: Thymic Hyperplasia in the Setting of Graves' Disease
  Michael Voss, Zeb Saeed, Diane Donegan> ;The American Journal of Medicine. 2020 Mar 1
• 2 citations
  CURRENT KNOWLEDGE AND PRACTICES OF HEATH CARE PROFESSIONALS ON OPIOID-INDUCED ADRENAL INSUFFICIENCY
  Zeb Saeed, Irina Bancos, Diane Donegan> ;Endocrine Practice. 2019 Jun 6
• 2 citations
  Opioid induced adrenal insufficiency: what is new?
  Diane Donegan> ;Current Opinion in Endocrinology, Diabetes and Obesity. 2019 Jun 1
• Prevalence of Opioid-Induced Adrenal Insufficiency in Patients Taking Chronic Opioids.
  Taoran Li, Julie L. Cunningham, Wesley P. Gilliam, Larissa L. Loukianova, Diane Donegan, Irina Bancos> ;The Journal of Clinical Endocrinology and Metabolism. 2019 Apr 15
• 6 citations
  MANAGEMENT AND OUTCOMES OF GIANT PROLACTINOMA: A SERIES OF 71 PATIENTS.
  Oksana Hamidi, Jamie J. Van Gompel, Lucinda M. Gruber, Nana Esi Kittah, Diane Donegan, Kenneth A. Philbrick, Kelly K. Koeller, Dana Erickson, Neena Natt, Todd B. Nippo...> ;Endocrine Practice. 2019 Apr 1
• 12 citations
  Corticotropin hormone assay interference: A case series.
  Diane Donegan, Alicia Algeciras-Schimnich, Oksana Hamidi, William F. Young, Todd B. Nippoldt, Irina Bancos, Dana Erickson> ;Clinical Biochemistry. 2019 Jan 1
• 2 citations
  NECESSITY OF MULTIMODAL TREATMENT OF ACROMEGALY AND OUTCOMES
  Diane Donegan, Nicole M. Iñiguez-Ariza, Anu Sharma, Todd B. Nippoldt, William F. Young, Jamie J. Van Gompel, John L. D. Atkinson, Fredric B. Meyer, Bruce E. Pollock, N...> ;Endocrine Practice. 2018 Jul 26
• 12 citations
  Opioid-Induced Adrenal Insufficiency.
  Diane Donegan, Irina Bancos> ;Mayo Clinic proceedings. 2018 Jul 1
• 18 citations
  Long-term metabolic risk for the metabolically healthy overweight/obese phenotype.
  A. E. Espinosa de Ycaza, Diane Donegan, Michael D. Jensen> ;International Journal of Obesity. 2018 Mar 1
• 1 citations
  Clinical Features of a Family with Multiple Endocrine Neoplasia Type 2A Caused by the D631Y RET Mutation.
  Naykky Singh Ospina, Spyridoula Maraka, Diane Donegan, John C. Morris> ;Thyroid. 2017 Oct 1
• 1 citations
  ANTHROPOMETRIC FEATURES ARE NOT PREDICTIVE OF 72-HOUR FAST DURATION IN INSULINOMAS
  Diane Donegan, Iva Jakubikova, Adrian Vella> ;Endocrine Practice. 2017 Jun 14
• 2 citations
  Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome—Clues to a Safer Diagnostic Process
  Naykky Singh Ospina, Diane Donegan, Rene Rodriguez-Gutierrez, Zahraa Al-Hilli, William F. Young> ;The American Journal of Medicine. 2017 May 1
• 3 citations
  The effect of growth hormone replacement in patients with hypopituitarism on pituitary tumor recurrence, secondary cancer, and stroke.
  Sina Jasim, Fares Alahdab, Ahmed T. Ahmed, Shrikant Tamhane, Anu Sharma, Diane Donegan, Todd B. Nippoldt, M. Hassan Murad> ;Endocrine. 2017 May 1
• 9 citations
  Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours.
  Diane Donegan, N. Singh Ospina, Rene Rodriguez-Gutierrez, Zahraa Al-Hilli, Geoffrey B. Thompson, Bart L. Clarke, William F. Young> ;Clinical Endocrinology. 2017 Feb 1
• 6 citations
  Surgical Outcomes of Prolactinomas in Recent Era: Results of a Heterogenous Group
  Diane Donegan, John L. D. Atkinson, Mark E. Jentoft, Neena Natt, Tod B. Nippoldt, Bradley J. Erickson, Fredric B. Meyer, Dana Erickson> ;Endocrine Practice. 2017 Jan 1
• 7 citations
  PAPP-A in normal human mesangial cells: effect of inflammation and factors related to diabetic nephropathy.
  Diane Donegan, Laurie K. Bale, Cheryl A. Conover> ;Journal of Endocrinology. 2016 Oct 1
• 4 citations
  Clinical Consequences of a Change in Anti-Thyroglobulin Antibody Assays During the Follow-up of Patients with Differentiated Thyroid Cancer
  Diane Donegan, Bryan McIver, Alicia Algeciras-Schimnich> ;Endocrine Practice. 2014 Oct 1
• 7 citations
  Management of parenteral nutrition associated hyperglycaemia: a comparison of subcutaneous and intravenous insulin regimen.
  K Neff, Diane Donegan, J MacMahon, C O’Hanlon, N Keane, A Agha, C Thompson, Diarmuid Smith> ;Irish Medical Journal. 2014 May 1
• 3 citations
  69-year-old man with recurrent episodes of confusion and diaphoresis.
  Diane Donegan, Adrian Vella> ;Mayo Clinic proceedings. 2013 Apr 1
• 1 citations
  Hypoglycemia after simultaneous pancreas-kidney transplant: fact or factitious?
  Diane Donegan, David P. Hickey, Diarmuid Smith> ;Pancreas. 2012 Aug 1
• Join now to see all

Lectures

• Early Career Forum 
  ENDO 2019 - New Orleans, LA - 3/22/2019